Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for IMMU stock. Download IMMU report.
Research Report
Get the full report for FREE
Date:Aug 12, 2009
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download IMMU report
  
Example preview: Research report for Immunomedics, Inc (IMMU) Research report for Immunomedics, Inc (IMMU) Research report for Immunomedics, Inc (IMMU) Research report for Immunomedics, Inc (IMMU)
   

Cash Flow for Immunomedics, Inc (IMMU)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
Symbol:  | Recent Quotes powered by
  quotemedia.com
Cash Flow for Immunomedics Inc.  (IMMU) 
$ 3.55   0.10 (+2.90%) Volume: 879.65 k 4:00 PM EST Nov 20, 2009
After Hours:  $ 3.5599   0.0099 (+0.28%) Volume: 13.59 k 4:48 PM EST Nov 20, 2009
Statement: View:
Cash Flow in Thousands of Dollars
06/2009 06/2008 06/2007 06/2006 06/2005
Net Income 2,274 (22,909) (16,656) (28,764) (26,758)
Depreciation & Amortization 1,484 1,559 1,618 1,779 1,863
Deferred Income Taxes - - - - -
Operating Losses (69) 56 (35) 39,913 (1,167)
Extraordinary Losses - - - - -
Decrease in Receivables (545) (433) (202) (59) 485
Decrease in Inventories 237 (162) 233 (53) (181)
Decrease in Other Current Assets (354) 54 (113) 183 (43)
Increase in Payables 564 573 (725) (1,878) 3,126
Increase in Other Current Liabilities - - - - -
Decrease in Other Working Capital 41 (1,841) (446) (26) -
Other Non-Cash Items 43,501 7,353 3,380 7 10
Net Cash from Continuing Operations 21,342 (15,736) (17,917) 12,145 (22,182)
Net Cash from Discontinued Operations - - - - -
Cash from Operating Activities 21,342 (15,736) (17,917) 12,145 (22,182)
Sale of Property, Plant, Equipment - - - - -
Sale of Short Term Investments - 338,145 204,060 5,448 9,268
Purchase of Property, Plant, Equipment (640) (174) (429) (123) (483)
Acquisitions - - - - -
Purchase of Short Term Investments - (334,000) (228,985) (1,650) (7,357)
Other Investment Changes, Net - - - - -
Cash from Investing Activities 60 3,971 (25,354) 3,675 1,428
Issuance of Debt - - - - 30,168
Issuance of Capital Stock - 84 22,757 96 13,965
Repayment of Debt - (1,275) (1,275) (1,275) (20,575)
Repurchase of Capital Stock - - - - -
Payment of Cash Dividends - - - - -
Other Financing Charges, Net (144) - - 14,300 -
Cash from Financing Activities (144) (1,191) 21,481 13,120 23,558
Effect of Exchange Rate Changes - - - - -
Net Change in Cash 21,258 (12,956) (21,790) 28,940 2,804
Cash at Beginning of Year 6,132 19,088 40,878 11,937 9,133
Cash at End of Period 27,391 6,132 19,088 40,878 11,937

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, financials by Morningstar.  Terms of Use. 
   
 
Home > Companies > Immunomedics, Inc